Content area
Full Text
To the Editor: In their interim analysis of the Mammary Oncology Assessment of LEE011’s (Ribociclib’s) Efficacy and Safety (MONALEESA-2) trial, Hortobagyi et al. (Nov. 3 issue)1 report that the addition of ribociclib to letrozole enhanced the efficacy and improved the clinical outcome of first-line treatment in patients with...